Latest News and Press Releases

SAN CLEMENTE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...

Second quarter revenue of $14.6M, +18% year-over-year growth; IFRS gross margin of 76.1%Second quarter pulse recurring revenue of $6.0M, +83% year-over-year growthFirst half revenue of $27.8M, +22%...

– Approval by Health Canada regulatory authority immediately clears the way for Pure Impact™ with PlyoPulse™ device launch and commercialization in Canada – Canada Represents Another Substantial...

First quarter revenue of $13.2M, +27% year-over-year growth; IFRS gross margin of 75.2%First quarter pulse recurring revenue of $4.7M, +118% year-over-year growth   IFRS and non-IFRS...

SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide,...

–  Full fiscal 2023 revenue of $50.3M, +41% year-over-year growth; gross margin of 74.5% –  Full fiscal 2023 pulse recurring revenue of $13.0M, +81% year-over-year growth –  Fourth quarter revenue...

SAN CLEMENTE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, is excited to...

SAN CLEMENTE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...

SAN CLEMENTE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners...

Pure Impact™ with PlyoPulse™ technology is a direct add-on Body module to the existing FDA cleared Sofwave medical aesthetic device platformThe PlyoPulse™ technology is an EMS (Electrical Muscle...